Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients

[1]  K. Matsumoto,et al.  High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. , 1996, The Journal of clinical endocrinology and metabolism.

[2]  G. Pacini,et al.  Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. , 1996, Metabolism: clinical and experimental.

[3]  G. Dailey,et al.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.

[4]  C. Rantzau,et al.  Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. , 1995, The American journal of physiology.

[5]  A. Vaag,et al.  Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[6]  L. Groop,et al.  Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[7]  P. Vollenweider,et al.  Mechanisms of dexamethasone-induced insulin resistance in healthy humans. , 1994, The Journal of clinical endocrinology and metabolism.

[8]  A. Vaag,et al.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. , 1994, The Journal of clinical investigation.

[9]  R N Bergman,et al.  The Contribution of Insulin-Dependent and Insulin-Independent Glucose Uptake to Intravenous Glucose Tolerance in Healthy Human Subjects , 1994, Diabetes.

[10]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[11]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[12]  R. DeFronzo,et al.  The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents , 1992, Diabetes.

[13]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[14]  C. Östenson,et al.  Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice. , 1992, The American journal of physiology.

[15]  M. Vranic,et al.  The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Srivastava,et al.  Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by epinephrine. , 1992, The American journal of physiology.

[17]  A. Vaag,et al.  Insulin Resistance in Skeletal Muscles in Patients With NIDDM , 1992, Diabetes Care.

[18]  L. Groop,et al.  INSULIN RESISTANCE AND INSULIN DEFICIENCY IN THE PATHOGENESIS OF POSTTRANSPLANTATION DIABETES IN MAN , 1992, Transplantation.

[19]  A. Vaag,et al.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[20]  R. DeFronzo,et al.  The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.

[21]  K. Osei,et al.  Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM , 1991, Diabetes Care.

[22]  D. Porte.  β-cells in type II diabetes mellitus , 1991, Diabetes.

[23]  D. Porte.  Banting lecture 1990. Beta-cells in type II diabetes mellitus. , 1991, Diabetes.

[24]  R C Boston,et al.  Application of the SAAM modeling program to minimal model analysis of intravenous glucose tolerance test data. , 1990, Computer methods and programs in biomedicine.

[25]  D. Porte,et al.  Islet Function and Insulin Sensitivity in the Non‐diabetic Offspring of Conjugal Type 2 Diabetic Patients , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[26]  B. Rn,et al.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. , 1989 .

[27]  R. Bergman.  Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[28]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[29]  R C Boston,et al.  Alternative method for minimal model analysis of intravenous glucose tolerance data. , 1989, The American journal of physiology.

[30]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[31]  R. DeFronzo.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[32]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[33]  R. Rizza,et al.  Effects of glucocorticoids on carbohydrate metabolism. , 1988, Diabetes/metabolism reviews.

[34]  V. Grill,et al.  Pathogenesis of non-insulin dependent diabetes mellitus , 1988 .

[35]  A. Baron,et al.  In Vivo Regulation of Non-Insulin-Mediated and Insulin-Mediated Glucose Uptake by Cortisol , 1987, Diabetes.

[36]  S. O’Rahilly,et al.  BETA-CELL DYSFUNCTION, RATHER THAN INSULIN INSENSITIVITY, IS THE PRIMARY DEFECT IN FAMILIAL TYPE 2 DIABETES , 1986, The Lancet.

[37]  H C Lukaski,et al.  Assessment of fat-free mass using bioelectrical impedance measurements of the human body. , 1985, The American journal of clinical nutrition.

[38]  Raymond C. Boston,et al.  Modeling with SAAM and its advancement in association with the study of mineral metabolism , 1984 .

[39]  T. Lövgren,et al.  Europium as a label in time-resolved immunofluorometric assays. , 1984, Analytical biochemistry.

[40]  R C Boston,et al.  Conversational SAAM--an interactive program for kinetic analysis of biological systems. , 1981, Computer programs in biomedicine.

[41]  C Cobelli,et al.  Quantitative Estimation of Beta Cell Sensitivity to Glucose in the Intact Organism: A Minimal Model of Insulin Kinetics in the Dog , 1980, Diabetes.

[42]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[43]  S. Fajans,et al.  Levels of Plasma Insulin During Cortisone Glucose Tolerance Tests in “Nondiabetic” Relatives of Diabetic Patients: Implications of Diminished Insulin Secretory Reserve in Subclinical Diabetes , 1970, Diabetes.

[44]  M BERMAN,et al.  THE FORMULATION AND TESTING OF MODELS , 1963, Annals of the New York Academy of Sciences.

[45]  S. Fajans,et al.  The prediabetic state. A concept of dynamic resistance to a genetic diabetogenic influence. , 1962, The American journal of medicine.

[46]  S. Fajans,et al.  An Approach to the Prediction of Diabetes Mellitus by Modification of the Glucose Tolerance Test with Cortisone , 1954, Diabetes.